Direct visualization and quantitation of cytomegalovirus-specific CD8+ cytotoxic T-lymphocytes in liver transplant patients

Transplantation

Volumn 69, Issue 11, 2000, Pages 2251-2259

  Singhal, Saket ^a,c   Shaw, Jean C ^a   Ainsworth, Jenni ^a   Hathaway, Mark ^a   Gillespie, Geraldine M A ^b   Paris, Holly ^a   Ward, Kim ^a   Pillay, Deenan ^a   Moss, Paul A H ^a   Mutimer, David J ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CD8 ANTIGEN; CORTICOSTEROID; CYCLOSPORIN; HLA B ANTIGEN; TACROLIMUS;

ANTIGEN SPECIFICITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; DIAGNOSTIC VALUE; GRAFT REJECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RANDOMIZED CONTROLLED TRIAL; VIRUS REACTIVATION;

EID: 18744429869     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200006150-00006     Document Type: Article

References (35)

1. Barkholt L, Ericzon BG, Tollemar J, et al. Infections in human liver recipients: different patterns early and late after transplantation. Transpl Int 1993; 6: 77.
2. Paya CV, Wiesner RH, Hermans PE, et al. Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation: a prospective multivariate time-dependant analysis. J Hepatol 1993; 18: 185.
3. Singh N, Dummer JS, Kusne S, et al. Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies. J Infect Dis 1988; 158: 124.
4. O'Grady JG, Alexander GJ, Sutherland S, et al. Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile-duct syndrome after liver transplantation. Lancet 1988; 2: 302.
5. van Dorp WT, Jonges E, Bruggeman CA, Daha MR, van Es LA, van der Woude FJ. Direct induction of MHC class I, but not class II, expression on endothelial cells by cytomegalovirus infection. Transplantation 1989; 48: 469.
6. Mutimer DJ. Opportunistic infection after liver transplantation. In: Arroyo V, Bosch J, Rodes J, eds. Treatments in hepatology. Barcelona: Masson SA, 1995: 227.
7. Sayage LH, Gonwa TA, Goldstein RM, Husberg BS, Klintmalm GB. Cytomegalovirus infection in orthotopic liver transplantation. Transpl Int 1989; 2: 96.
8. Dunn DL, Mayoral JL, Gillingham KJ, et al. Treatment of invasive cytomegalovirus disease in solid organ transplant recipients with ganciclovir. Transplantation 1991; 51: 98.
9. Harbison MA, de Girolami PC, Jenkins RL, Hammer SM. Ganciclovir therapy of severe cytomegalovirus infections in solid organ transplant recipients. Transplantation 1988; 46: 82.
10. Paya CV, Hermans PE, Smith TF, et al. Efficacy of ganciclovir in liver and kidney transplant recipients with severe cytomegalovirus infection. Transplantation 1988; 46: 229.
11. George MJ, Syndman DR, Werner BG, et al. Use of ganciclovir and cytomegalovirus immune globulin to treat CMV pneumonia in orthotopic liver transplant recipients. Transplant Proc 1993; 25: 22.
12. Gorensek MJ, Carey WD, Vogt D, Goormastic M. A multivariate analysis of risk factors for cytomegalovirus infection in liver-transplant recipients. Gastroenterology 1990; 98: 1326.
13. van Son WJ, The TH. Cytomegalovirus infection after organ transplantation: an update with special emphasis on renal transplantation. Transpl Int 1989; 2: 147.
14. Mutimer DJ, Mirza D, Shaw J, O'Donnell K, Elias E. Enhanced (cytomegalovirus) viral replication associated with septic bacterial complications in liver transplant recipients. Transplantation 1997; 63: 1411.
15. The TH, van der Ploeg M, van den Berg AP, Vlieger Am, van der Giessen M, van Son WJ. Direct detection of cytomegalovirus in peripheral blood leukocytes: a review of the antigenaemia assay and polymerase chain reaction. Transplantation 1992; 54: 193.
16. Mutimer DJ, Matyi-Toth A, Shaw J, Elias E, O'Donnell K, Stalhandske P. Patterns of viraemia in liver transplant recipients with symptomatic cytomegalovirus infection. Transplantation 1997; 63: 68.
17. Rook AH, Quinnan GV Jr, Frederick WJ, et al. Importance of cytotoxic lymphocytes during cytomegalovirus infection of renal transplant recipients. Am J Med 1984; 76: 385.
18. Quinnan GV Jr, Kirmani N, Rook AH, et al. Cytotoxic T-cells in cytomegalovirus infection. N Engl J Med 1982; 307: 6.
19. Reusser P, Riddell SR, Meyers JD, Greenberg PD. Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 1991; 78: 1373.
20. Reusser P, Attenhofer R, Hebart H, Helg C, Chapuis B, Einsele H. Cytomegalovirus-specific T-cell immunity in recipients of autologous peripheral blood stem cell or bone marrow transplants. Blood 1997; 89: 3873.
21. Wills MR, Carmichael AJ, Mynard K, et al. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J Virol 1996; 70: 7569.
22. Lefkovits I, Waldmann H. Limiting dilution analysis of cells of the immune system. Cambridge: Cambridge University Press, 1979: 60.
23. Doherty PC. The numbers game for virus-specific CD8+ T cells. Science 1998; 280: 227.
24. Altman JD, Moss PAH, Goulder PJR, et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 1996; 274: 94.
25. Dunbar PR, Ogg GS, Chen J, Rust N, van der Bruggen P, Cerundolo V. Direct isolation, phenotyping and cloning of low-frequency antigen-specific cytotoxic T lymphocytes from peripheral blood. Curr Biol 1998; 8: 413.
26. Callan MFC, Tan L, Annels N, et al. Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo. J Exp Med 1998; 187: 1395.
27. He X-S, Rehermann B, Lopez-Labrador FX, et al. Quantitative analysis of hepatitis C virus-specific CD8+ T cells in peripheral blood and liver using peptide-MHC tetramers. Proc Natl Acad Sci 1999; 96: 5692.
28. Bunce M, O'Neill CM, Barnardo MC, et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995; 46: 355.
29. Walter EA, Greenberg PD, Gilbert MJ, et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 1995; 333: 1038.
30. Boppana SB, Britt WJ. Recognition of human cytomegalovirus gene products by HCMV-specific cytotoxic T cells. Virology 1996; 222: 293.
31. Oukka M, Manuguerra JC, Livaditis N, et al. Protection against lethal viral infection by vaccination with nonimmunodominant peptides. J Immunol 1996; 157: 3039.
32. van der Most RG, Sette A, Oseroff C, et al. Analysis of cytotoxic T-cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection. J Immunol 1996; 157: 5543.
33. Gallimore A, Hengartner H, Zinkernagel R. Hierarchies of antigen-specific cytotoxic T-cell responses. Immunol Rev 1998; 164: 29.
34. Quinnan GV, Manischewitz JE. The role of natural killer cells and antibody-dependant cell-mediated cytotoxicity during murine cytomegalovirus infection. J Exp Med 1979; 150: 1549.
35. van Dam JG, Damoiseaux JG, van der Heijden HA, Grauls G, van Breda-Vriesman PJ, Bruggeman CA. Infection with rat cytomegalovirus (CMV) in the immunocompromised host is associated with the appearance of a T cell population with reduced CD8 and T cell receptor (TCR) expression. Clin Exp Immunol 1997; 110: 349.